ESC 365 - Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

ACVC Premium Access

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

Session: Dual or triple antithrombotic therapy?

Topic: Clinical

Speaker: Professor K. Huber (Vienna, AT)

Event: Acute Cardiovascular Care 2019

Congress Presentation

Add to my library

About the speaker

Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

54 presentations

10 followers

5 more presentations in this session

Positioning of the topic - DAT for all ACS patients with atrial fibrillation receiving coronary stents

Speaker: Professor K. Huber (Vienna, AT)

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - PRO

Speaker: Doctor A. Sambola (Barcelona, ES)

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - CONTRA

Speaker: Doctor A. Rubboli (Ravenna, IT)

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Rebuttal

Speaker: Doctor A. Rubboli (Ravenna, IT) Doctor A. Sambola (Barcelona, ES)

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Conclusion.

Speaker: Professor P. Clemmensen (Hamburg, DE)

Access the full session

Dual or triple antithrombotic therapy?

Speakers: Professor K. Huber, Professor K. Huber, Doctor A. Sambola, Doctor A. Rubboli, Doctor A. Rubboli...

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources